INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/26/2026
Back to search
Official data from USPTO
EMPEROR HEART FAILURE STUDIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
02/27/2026
Trademark type
Combined
Nice classes
41, 42
Filing date
08/22/2017
Registration date
06/05/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2024
Last transaction
02/27/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
27
Owner location
DE
Examiner
HENRY, NAKIA D
Law office
O20
Current location
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
Mark description
The mark consists of the wording "Emperor" in gray with a stylized "O" that includes a transparent heart in the middle, a red and blue line extend from the top of the letter "o" like antennas and each contain a circle near the end of the line; the purple wording "Heart Failure Studies" is beneath the wording "Emperor". There is no claim to background color.
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Martin J. Beran Ostrolenk Faber LLP
Technical classification
Nice Classes
Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
publication of printed matter with the results of clinical studies involving pharmaceutical preparationsincluding printed matter in electronic form
Class 42
Medical and scientific research in the fields of cardiovascular and metabolic diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Publications
History of USPTO decisions and trademark events.
28 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/10/2026
INPC
INVALIDATION PROCESSED
02/10/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/20/2025
C71T
CANCELLED SECTION 71
12/20/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/05/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/06/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/13/2018
FIMP
FINAL DISPOSITION PROCESSED
09/13/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/05/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/20/2018
PUBO
PUBLISHED FOR OPPOSITION
03/20/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/28/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/13/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2018
RFNT
REFUSAL PROCESSED BY IB
01/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/14/2017
RFRR
REFUSAL PROCESSED BY MPU
12/14/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/01/2017
CNRT
NON-FINAL ACTION WRITTEN
11/30/2017
DOCK
ASSIGNED TO EXAMINER
11/22/2017
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/02/2017
Continuous trademark protection
Get notified about every new filing that threatens EMPEROR HEART FAILURE STUDIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.